Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 16, Number 1—January 2010

Recombinant Canine Coronaviruses in Dogs, Europe

Nicola DecaroComments to Author , Viviana Mari, Gabriella Elia, Diane D. Addie, Michele Camero, Maria Stella Lucente, Vito Martella, and Canio Buonavoglia
Author affiliations: Faculty of Veterinary Medicine of Bari, Valenzano, Italy (N. Decaro, V. Mari, G. Elia, M. Camero, M.S. Lucente, V. Martella, C. Buonavoglia); Feline Institute Pyrenees, Etchebar, France (D.D. Addie)

Main Article

Table 3

Percent nucleotide identity of representative TGEV-like CCoVs to group-1a CoV reference strains in the 5′ and 3′ ends of the spike gene from dogs from Europe, 2001–2008*

CoV strain GenBank accession no. % Identity
5′ end† 3′ end‡
CCoV-IIb-341/05 EU856361 88.1–99.3 94.7–99.4
CCoV-IIb-174/06 EU856362 86.8–99.0 93.3–97.0
CCoV-IIb-430/07 EU924790 85.9–97.3 92.7–97.0
CCoV-IIb-119/08 EU924791 89.1–99.0 93.7–99.8
CCoV-IIb-UCD1 AF116248 76.6–85.7 NA
TGEV-Purdue NC_002306 76.6–84.4 91.4–93.1
TGEV-TS DQ201447 76.2–84.4 90.8–92.5
TGEV-96-1933 AF104420 74.0–81.8 87.1–88.8
PRCoV-RM4 Z24675 NA 90.2–91.6
PRCoV-86-137004 X60089 NA 90.2–91.6
CCoV-IIa-Insavc-1 D13096 35.4–38.3 92.1–95.3
CCoV-IIa-CB/05 DQ112226 35.1–37.7 93.7–99.0
CCoV-IIa-BGF10 AY342160 34.2–37.5 90.8–94.3
FCoV-II-79-1146 NC_007025 34.0–36.6 90.2–91.6
FCoV-II-79-1683 X80799 34.6–37.5 90.4–91.9
CCoV-I-Elmo/02 AY307020 37.6–40.4 61.8–62.8
CCoV-I-23/03 AY307021 31.8–34.8 60.3–61.2
FCoV-I-KU-2 D32044 37.4–40.8 59.1–60.3
FCoV-I-Black EU186072 36.2–39.3 58.9–61.0
FCoV-I-UCD1 AB088222 38.3–42.7 57.9–58.9

*TGEV, porcine transmissible gastroenteritis virus; CCoV, canine coronavirus; NA, sequence not available.
†Nucleotides 1–305 of the spike gene of reference strain CCoV-IIb-341/05.
‡Nucleotides 3574–4085 of the spike gene of reference strain CCoV-IIb-341/05.

Main Article

Page created: March 31, 2011
Page updated: March 31, 2011
Page reviewed: March 31, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.